Jane Street’s Bio-Rad Laboratories Class A BIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-1,800
Closed -$434K 10791
2025
Q2
$434K Buy
+1,800
New +$426K ﹤0.01% 7197
2024
Q4
Sell
-600
Closed -$201K 9402
2024
Q3
$201K Sell
600
-1,500
-71% -$476K ﹤0.01% 8641
2024
Q2
$574K Buy
2,100
+600
+40% +$175K ﹤0.01% 6793
2024
Q1
$519K Sell
1,500
-2,800
-65% -$921K ﹤0.01% 6600
2023
Q4
$1.39M Buy
4,300
+3,400
+378% +$1.07M ﹤0.01% 4962
2023
Q3
$323K Buy
900
+300
+50% +$116K ﹤0.01% 6959
2023
Q2
$227K Buy
600
+100
+20% +$40.7K ﹤0.01% 7518
2023
Q1
$240K Sell
500
-1,100
-69% -$515K ﹤0.01% 7552
2022
Q4
$673K Sell
1,600
-15,400
-91% -$6.22M ﹤0.01% 5643
2022
Q3
$7.09M Sell
17,000
-6,000
-26% -$2.99M ﹤0.01% 2107
2022
Q2
$11.4M Buy
23,000
+15,800
+219% +$8.23M ﹤0.01% 1590
2022
Q1
$4.05M Buy
7,200
+6,300
+700% +$3.8M ﹤0.01% 3401
2021
Q4
$680K Buy
900
+400
+80% +$299K ﹤0.01% 6686
2021
Q3
$373K Buy
500
+100
+25% +$74.9K ﹤0.01% 7785
2021
Q2
$258K Sell
400
-300
-43% -$183K ﹤0.01% 8409
2021
Q1
$400K Sell
700
-100
-13% -$59.2K ﹤0.01% 7201
2020
Q4
$466K Buy
+800
New +$456K ﹤0.01% 5847
2020
Q3
Sell
-500
Closed -$226K 7148
2020
Q2
$226K Buy
+500
New +$221K ﹤0.01% 6216

Other funds holding BIO

Jane Street's BIO Position: Q1 2026 in Review

Jane Street sold out of Bio-Rad Laboratories Class A (BIO) in Q1 2026, closing a stake of 73,967 shares — an estimated $21.3M sold.

Jane Street first reported a position in BIO in Q3 2013 and held it in 37 quarters. The position peaked at $22.4M in Q4 2025. 392 funds tracked by Wall St. Rank hold BIO as of Q1 2026.

  • Jane Street reported no remaining Bio-Rad Laboratories Class A position as of Q1 2026 after selling out during the quarter.
  • Jane Street sold 73,967 Bio-Rad Laboratories Class A shares in Q1 2026, an estimated $21.3M.
  • Jane Street first reported a position in Bio-Rad Laboratories Class A in Q3 2013 and held it in 37 quarters.
  • Jane Street's Bio-Rad Laboratories Class A position peaked at $22.4M in Q4 2025.
  • 392 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.